Fibulin-1 Protein in Breast Cancer
Author Information
Author(s): Greene L M, Twal W O, Duffy M J, McDermott E W, Hill A D, O'Higgins N J, McCann A H, Dervan P A, Argraves W S, Gallagher W M
Primary Institution: University College Dublin
Hypothesis
The study evaluates fibulin-1 protein expression in human breast tumors and its correlation with estrogen receptor status.
Conclusion
Fibulin-1 protein expression is elevated in breast carcinomas compared to normal breast tissue.
Supporting Evidence
- Fibulin-1 protein expression was significantly increased in breast carcinomas compared to normal breast tissue.
- The study found no significant difference in fibulin-1 expression between normal breast tissue and benign tumors.
- Altered processing of fibulin-1 was associated with breast cancer.
- Fibulin-1 processing was more extensive in ERα-positive than in ERα-negative breast carcinomas.
Takeaway
This study found that a protein called fibulin-1 is more common in breast cancer than in healthy breast tissue.
Methodology
The study used immunohistochemistry and immunoblot analysis to assess fibulin-1 expression in breast tissue samples.
Limitations
The study had a limited number of benign tumors examined, which may affect the significance of some comparisons.
Participant Demographics
The study included 62 patients with various breast conditions, including normal, benign, and malignant tumors.
Statistical Information
P-Value
0.0005
Statistical Significance
p=0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website